These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15295690)

  • 1. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
    Elliott AM; Luzze H; Quigley MA; Nakiyingi JS; Kyaligonza S; Namujju PB; Ducar C; Ellner JJ; Whitworth JA; Mugerwa R; Johnson JL; Okwera A
    J Infect Dis; 2004 Sep; 190(5):869-78. PubMed ID: 15295690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
    Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
    J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
    Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
    N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
    Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
    Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
    Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
    J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct therapy with corticosteroids or paracentesis for treatment of tuberculous pleural effusion.
    Mansour AA; Al-Rbeay TB
    East Mediterr Health J; 2006 Sep; 12(5):504-8. PubMed ID: 17333787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.
    Mayanja-Kizza H; Jones-Lopez E; Okwera A; Wallis RS; Ellner JJ; Mugerwa RD; Whalen CC;
    J Infect Dis; 2005 Mar; 191(6):856-65. PubMed ID: 15717259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
    Chetchotisakd P; Sungkanuparph S; Thinkhamrop B; Mootsikapun P; Boonyaprawit P
    HIV Med; 2004 May; 5(3):140-3. PubMed ID: 15139978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
    Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
    Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
    Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
    J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up.
    Strang JI; Nunn AJ; Johnson DA; Casbard A; Gibson DG; Girling DJ
    QJM; 2004 Aug; 97(8):525-35. PubMed ID: 15256610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
    J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.
    Hakim JG; Ternouth I; Mushangi E; Siziya S; Robertson V; Malin A
    Heart; 2000 Aug; 84(2):183-8. PubMed ID: 10908256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.
    Breen RA; Miller RF; Gorsuch T; Smith CJ; Ainsworth J; Ballinger J; Swaden L; Cropley I; Johnson MA; Lipman MC
    J Infect Dis; 2006 May; 193(10):1437-40. PubMed ID: 16619192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of tuberculous pleurisy].
    Miyamoto J; Koga H; Kohno S; Matsuda H; Yoshitomi Y; Miyazaki Y; Kaku M; Miyazaki T; Watanabe K; Oe T
    Kekkaku; 1992 Jul; 67(7):509-13. PubMed ID: 1434315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
    Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.